Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2014 from OUS - Rheumatology Research Group

20 publications found

Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
Ann Rheum Dis, 74 (8), 1515-21
DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010

Bergersen TK, Hoffmann-Vold AM, Midtvedt Ø, Gran JT, Mørk C, Toska K, Elstad M (2014)
Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
PubMed 24847906

Clarke-Jenssen AC, Mengshoel AM, Strumse YS, Forseth KO (2014)
Effect of a fibromyalgia rehabilitation programme in warm versus cold climate: a randomized controlled study
J Rehabil Med, 46 (7), 676-83
DOI 10.2340/16501977-1819, PubMed 24788929

Curran SA, Hollan I, Erridge C, Lappin DF, Murray CA, Sturfelt G, Mikkelsen K, Førre OT, Almdahl SM, Fagerhol MK, Goodyear CS, Riggio MP (2014)
Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis
PLoS One, 9 (5), e98627
DOI 10.1371/journal.pone.0098627, PubMed 24874661

Dobloug C, Garen T, Bitter H, Stjärne J, Stenseth G, Grøvle L, Sem M, Gran JT, Molberg Ø (2014)
Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
Ann Rheum Dis, 74 (8), 1551-6
DOI 10.1136/annrheumdis-2013-205127, PubMed 24695011

Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjärne J, Grøvle L, Gran JT, Molberg Ø (2014)
High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
Eur J Neurol, 22 (4), 672-e41
DOI 10.1111/ene.12627, PubMed 25530508

Ellis JA, Scurrah KJ, Li YR, Ponsonby AL, Chavez RA, Pezic A, Dwyer T, Akikusa JD, Allen RC, Becker ML, Thompson SD, Lie BA, Flatø B, Førre O, Punaro M, Wise C, Finkel TH, Hakonarson H, Munro JE (2014)
Epistasis amongst PTPN2 and genes of the vitamin D pathway contributes to risk of juvenile idiopathic arthritis
J Steroid Biochem Mol Biol, 145, 113-20
DOI 10.1016/j.jsbmb.2014.10.012, PubMed 25460303

Flåm ST, Gunnarsson R, Garen T, Norwegian MCTD Study Group, Lie BA, Molberg Ø (2014)
The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases
Rheumatology (Oxford), 54 (3), 528-35
DOI 10.1093/rheumatology/keu310, PubMed 25187641

Haugeberg G, Helgetveit KB, Førre Ø, Garen T, Sommerseth H, Prøven A (2014)
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
BMC Musculoskelet Disord, 15, 289
DOI 10.1186/1471-2474-15-289, PubMed 25182527

Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt Ø, Molberg Ø (2014)
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease
J Rheumatol, 42 (1), 60-3
DOI 10.3899/jrheum.140047, PubMed 25274890

Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B, EC-IBD Study Group (2014)
Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort
Scand J Gastroenterol, 50 (3), 300-5
DOI 10.3109/00365521.2014.991752, PubMed 25535653

Lerang K, Gilboe IM, Steinar Thelle D, Gran JT (2014)
Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study
Lupus, 23 (14), 1546-52
DOI 10.1177/0961203314551083, PubMed 25209070

Lorentzen AO, Sveberg L, Midtvedt Ø, Kerty E, Heuser K (2014)
Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice
Clin Neuropharmacol, 37 (5), 142-8
DOI 10.1097/WNF.0000000000000047, PubMed 25229171

Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R, Spanish GCA Consortium, Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T et al. (2014)
Influence of the IL17A locus in giant cell arteritis susceptibility
Ann Rheum Dis, 73 (9), 1742-5
DOI 10.1136/annrheumdis-2014-205261, PubMed 24919468

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Rodriguez-Rodriguez L, Narváez J, Blanco R, Ortego-Centeno N, Spanish GCA Consortium, Palm O, Diamantopoulos AP, Braun N, Moosig F, Witte T, Beretta L, Lunardi C, Cimmino MA, Vaglio A, Salvarani C, González-Gay MA, Martín J (2014)
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA
PLoS One, 9 (11), e113476
DOI 10.1371/journal.pone.0113476, PubMed 25409453

Midtvedt Ø, Gran JT, Solheim H, Kirkhus E, Spetalen S (2014)
[A man in his forties with swelling in both orbits]
Tidsskr Nor Laegeforen, 134 (15), 1472-6
DOI 10.4045/tidsskr.13.0115, PubMed 25138406

Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H et al. (2014)
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients
Arthritis Rheumatol, 66 (11), 3160-9
DOI 10.1002/art.38802, PubMed 25077692

Mochol M, Berg K, Midtvedt Ø, Ringstad G, Kerty E (2014)
[Woman with recurrent uveitis and neurological symptoms]
Tidsskr Nor Laegeforen, 134 (12-13), 1245-8
DOI 10.4045/tidsskr.13.0433, PubMed 24989204

Sanner H, Schwartz T, Flatø B, Vistnes M, Christensen G, Sjaastad I (2014)
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage
PLoS One, 9 (3), e92171
DOI 10.1371/journal.pone.0092171, PubMed 24647150

Selvaag AM, Aulie HA, Lilleby V, Flatø B (2014)
Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
Ann Rheum Dis, 75 (1), 190-5
DOI 10.1136/annrheumdis-2014-206034, PubMed 25362042

 
Page visits: 71614